top of page
Browse by category
Search


Johnson & Johnson MedTech launches the ETHICON 4000 Stapler
Johnson & Johnson MedTech has launched the ETHICON 4000 Stapler, an advanced surgical stapler designed to manage tissue complexities and...


Johnson & Johnson MedTech launches the DUALTO Energy System combining multiple energy modalities into an integrated platform for use across open and minimally invasive surgery
Johnson & Johnson MedTech has launched the DUALTO Energy System, a surgical solution that combines multiple energy modalities into an...


Novo Nordisk and Septerna to develop oral small molecule medicines for obesity
Novo Nordisk and Septerna have announced an exclusive global collaboration and license agreement to discover, develop and commercialise...


Fractyl Health submits of CTA module in Europe for RJVA-001
Fractyl Health has submitted the first module of its Clinical Trial Application (CTA) in Europe for the company’s gene therapy candidate...


Bariatric Solutions International's 20th Anniversary Supplement
To read or download this supplement in full, please click on the file below


FDA accepts filing application for oral semaglutide 25mg
Novo Nordisk has announced that the FDA accepted its New Drug Application (NDA) submission for an investigational once-daily, 25mg oral...


First RYGB cases performed with Johnson & Johnson MedTech’s OTTAVA Robotic Surgical System
Johnson & Johnson MedTech has completed the first cases in the clinical trial for the OTTAVA Robotic Surgical System, the first clinical...


Soleno Therapeutics launches VYKAT XR for patients with Prader-Willi syndrome
Soleno Therapeutics has launched VYKAT XR (diazoxide choline) extended-release tablets, the company’s treatment for hyperphagia in...


Pfizer to discontinue development oral GLP-1 receptor agonist Danuglipron
Pfizer has decided to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist,...


WL Gore launches Gore SYNECOR preperitoneal biomaterial in Europe, the Middle East and South Africa
WL Gore & Associates (Gore) has announced that GORE SYNECOR Preperitoneal Biomaterial is now available in Europe, Middle East and South...
Browse by tag






bottom of page